Volume 9, Issue A100 pp. 20-27
Stroke statement

Women Stroke Association statement on stroke

Francesca Romana Pezzella

Corresponding Author

Francesca Romana Pezzella

Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy

Correspondence: Francesca Romana Pezzella*, Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Piazza Carlo Forlanini 1, 00151 Rome, Italy.

E-mail: [email protected]

Search for more papers by this author
Paola Santalucia

Paola Santalucia

Direzione Scientifica and U.O. Medicina d'Urgenza, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milan, Italy

Search for more papers by this author
Rita Vadalà

Rita Vadalà

NeuroRadiology, IRCCS Fondazione S Lucia, Rome, Italy

Search for more papers by this author
Elisabetta Giugni

Elisabetta Giugni

Fondazione Biomedica Europea Onlus, Rome, Italy

Search for more papers by this author
Maria Luisa Zedde

Maria Luisa Zedde

Neurology Department, Arcispedale Santa Maria Nuova, Reggio nell'Emilia, Italy

Search for more papers by this author
Maria Sessa

Maria Sessa

Stroke Unit – Department of Neurology and Neurophysiology, San Raffaele Scientific Institute, Milan, Italy

Search for more papers by this author
Sabrina Anticoli

Sabrina Anticoli

Stroke Unit – Department of Emergency Medicine, AO S Camillo Forlanini, Rome, Italy

Search for more papers by this author
Valeria Caso

Valeria Caso

Stroke Unit, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy

Search for more papers by this author
on behalf of the Women Stroke Association

the Women Stroke Association

Search for more papers by this author
First published: 19 December 2013
Conflict of interest: None declared.

Abstract

We describe the current and future objectives of the Women Stroke Association, a nonprofit multidisciplinary organization promoting research awareness on medical, psychological, and social issues concerning women affected by cerebro-cardiovascular disease. In this paper, we deal with only cerebrovascular disease, whereas cardiovascular disorders will be addressed in a future paper. Gender differences in the clinical presentation of cerebrovascular diseases have been repeatedly suggested, and some treatment options may not be as effective and safe in men and women. For many years, women have either been underrepresented or excluded from randomized clinical trials, and the majority of therapeutic research has been carried on predominantly male populations. Furthermore, gender differences have been shown to contribute to different responses to cerebrovascular drugs in women when compared with men, regarding pharmacokinetics, pharmacodynamics, and physiology. In this statement, we discuss main research fields relevant to Women Stroke Association's mission and commitment, highlighting opportunities and critical from the women's health perspective. Future directions and goals of the Women Stroke Association arise from these considerations and represent the association's commitment to combating stroke.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.